Target intelligence / Profile preview

Ribosomal protein S3a pseudogene 38 (RPS3AP38)

Target: RPS3AP38
Molecular classification: Other, Pseudogene

Overview

RPS3AP38 is a noncoding processed pseudogene and does not encode a functional protein. It is a retrocopy, meaning it originated by reverse transcription of RPS3A mRNA and integration into the genome, but lacks regulatory elements and typically is transcriptionally inactive[9][7]. The parent gene, RPS3A, encodes a structural protein involved in the ribosome's small (40S) subunit, but RPS3AP38 itself does not participate in protein synthesis, signal transduction, disease processes, or serve as a known therapeutic target. There is no evidence of involvement of RPS3AP38 in biological pathways, drug interactions, or as a biomarker[5][7][9].

Other names: RPS3A pseudogene 38RPS3AP38RPS3A_17_1053ribosomal protein S3a pseudogene 38

Beyond the preview

Go deeper on Ribosomal protein S3a pseudogene 38 (RPS3AP38).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S3a pseudogene 38 (RPS3AP38).

Explore the full profile